Longitudinal Assessment of Glucocorticoid Toxicity Reduction in Patients With Severe Asthma Treated With Biologic Therapies
The Journal of Allergy and Clinical Immunology: In Practice · 2025
DOI: 10.1016/j.jaip.2024.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von P Jane McDowell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, Unite…. Hauptthemen laut MEDLINE: Asthma, Glucocorticoids, Anti-Asthmatic Agents, Biological Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Toxicities associated with oral corticosteroids (OCS) are well described. Targeted biologics for severe asthma (SA) substantially reduce OCS exposure with the potential to reduce cumulative OCS-related toxicities. The Glucocorticoid Toxicity Index (GTI) systematically assesses OCS-related toxicity; the GTI Aggregate Improvement Score (AIS) is a bidirectional measure of total toxicity change with a minimal clinically important difference (MCID) of ≤-10. OBJECTIVE: This study was a longitudinal assessment of patients with SA treated with biologic therapies to assess the trajectory of OCS-related toxicity and predictors of toxicity improvement. METHODS: A total of 89 patients with SA had GTI assessments at baseline and after 1 and 3 years of biologic therapy. RESULTS: At 3 years, daily prednisolone use continued to decrease (6.9 mg/day [4.0, 9.4] year 1 vs 0.8 mg/day [0.0, 3.7] year 3, P < .001), OCS-related toxicity continued to decline (AIS at 3 years -36 [-94, 19]), and 61% (54 of 89) met the AIS MCID. There was a significant positive correlation between toxicity outcomes at years 1 and 3 (ρ 0.65, P < .001). Nearly half (49%) met the AIS MCID at both years 1 and 3, but 29% of the cohort did not meet the AIS MCID at either time point. Toxicity change at year 1 was predictive of toxicity change at year 3 for 79%. Toxicity reduction was not proportional to OCS reduction; there were no prebiologic characteristics that predicted toxicity reduction. CONCLUSIONS: After 3 years of biologic treatment, 61% of patients with SA had clinically significant toxicity improvement. Individual toxicity outcomes at year 1 are associated with longitudinal outcomes, suggesting that for some, additional interventions are needed alongside OCS reduction to decrease morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome-Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, United Kingdom; Department of Respiratory Medicine, Belfast City Hospital,…
- Centre for Public Health, School of Medicine, Dentistry, and Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
- Division of Rheumatology, Allergy, and Clinical Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
- Department of Respiratory Medicine, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom.
Zitieren
APA
McDowell, P. J., Busby, J., Stone, J. H., Butler, C. A., & Heaney, L. G. (2025). Longitudinal Assessment of Glucocorticoid Toxicity Reduction in Patients With Severe Asthma Treated With Biologic Therapies. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.10.024
Vancouver
McDowell PJ, Busby J, Stone JH, Butler CA, Heaney LG. Longitudinal Assessment of Glucocorticoid Toxicity Reduction in Patients With Severe Asthma Treated With Biologic Therapies. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2024.10.024
BibTeX
@article{McDowell2025,
author = {McDowell, P Jane and Busby, John and Stone, John H and Butler, Claire A and Heaney, Liam G},
title = {Longitudinal Assessment of Glucocorticoid Toxicity Reduction in Patients With Severe Asthma Treated With Biologic Therapies},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2025},
doi = {10.1016/j.jaip.2024.10.024}
}
EUVIMED